header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FIG-140319-12
Pruvot et al., 2014 - Developmental defects in zebrafish for classification of EGF pathway inhibitors. Toxicology and applied pharmacology   274(2):339-349 Full text @ Tox. App. Pharmacol.
ADDITIONAL FIGURES
EXPRESSION / LABELING:
Gene:
Fish:
Condition:
Anatomical Terms:
Stage: Day 4
PHENOTYPE:
Fish:
Condition:
Observed In:
Stage: Day 4

Fig. 6 ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Gene Expression Details
Gene Antibody Fish Conditions Stage Anatomy Assay
EGFP y1Tg control Day 4 caudal vein IFL
Day 4 dorsal aorta IFL
Day 4 dorsal longitudinal anastomotic vessel IFL
Day 4 intersegmental vessel IFL
y1Tg chemical treatment: pharmaceutical Day 4 caudal vein IFL
Day 4 dorsal aorta IFL
Day 4 dorsal longitudinal anastomotic vessel IFL
Day 4 intersegmental vessel IFL
y1Tg chemical treatment: pharmaceutical Day 4 caudal vein IFL
Day 4 dorsal aorta IFL
Day 4 dorsal longitudinal anastomotic vessel IFL
Day 4 intersegmental vessel IFL
y1Tg chemical treatment: pharmaceutical Day 4 caudal vein IFL
Day 4 dorsal aorta IFL
Day 4 dorsal longitudinal anastomotic vessel IFL
Day 4 intersegmental vessel IFL
y1Tg chemical treatment: pharmaceutical Day 4 caudal vein IFL
Day 4 dorsal aorta IFL
Day 4 dorsal longitudinal anastomotic vessel IFL
Day 4 intersegmental vessel IFL
y1Tg chemical treatment: pharmaceutical Day 4 caudal vein IFL
Day 4 dorsal aorta IFL
Day 4 dorsal longitudinal anastomotic vessel IFL
Day 4 intersegmental vessel IFL
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
y1Tg chemical treatment: pharmaceutical Day 4 blood vessel malformed, abnormal
Day 4 caudal vein blood circulation absent, abnormal
Day 4 intersegmental vessel blood circulation absent, abnormal
y1Tg chemical treatment: pharmaceutical Day 4 caudal vein blood circulation decreased process quality, abnormal
Day 4 dorsal longitudinal anastomotic vessel blood circulation absent, abnormal
y1Tg chemical treatment: pharmaceutical Day 4 intersegmental vessel blood circulation absent, abnormal
y1Tg chemical treatment: pharmaceutical Day 4 caudal vein blood circulation absent, abnormal
Day 4 dorsal longitudinal anastomotic vessel blood circulation absent, abnormal
Day 4 intersegmental vessel blood circulation absent, abnormal
Full text @ Tox. App. Pharmacol.